Basic Information
| LncRNA/CircRNA Name | LINC00473 |
| Synonyms | NA |
| Region | GRCh38_6:165908802-165988048 |
| Ensemble | ENSG00000223414 |
| Refseq | NR_026860 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | qPCR, RIP |
| Sample | breast cancer cell line(MCF-7 ) |
| Expression Pattern | up-regulated |
| Function Description | Here, we found that lncRNA LINC00473 is significantly upregulated in breast cancer cells. |
| Pubmed ID | 30848493 |
| Year | 2019 |
| Title | LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells. |
External Links
| Links for LINC00473 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |